MB

Manthan Bhavin Kothari

Active Director Director DIN 08691102
DIN 08691102 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Apr 2024
Shareholding value •••• Premium profile

About Manthan Bhavin Kothari

Data last updated:

Manthan Bhavin Kothari is a Director at D. C. Agencies Private Limited (since 2024), Director at Pearl Medicals Private Limited (since 2024) and Director at Dial Health Drug Supplies Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹331 Cr; the largest is D. C. Agencies Private Limited at ₹284 Cr (FY 2024). Earlier, Manthan Bhavin Kothari was an Additional Director at Avighna Medicare Private Limited (2024).

DIN 08691102
Primary Designation Director
Industry Pharma
First Appointment 22 Apr 2024
Oldest Company Age 27 yrs
Largest company D. C. Agencies Private Limited · ₹284 Cr (FY 2024)
Combined revenue ₹331 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
D. C. Agencies Private Limited U74999DL2016PTC304376
Director22 Aug 20242016₹284 Cr (FY 2024)Active
Pearl Medicals Private Limited U85120MH1999PTC449218
Director22 Apr 20241999₹46.69 Cr (FY 2022)Active
Director22 Aug 20242015₹27.3 Lakh (FY 2025)Active
Designated Partner19 Feb 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avighna Medicare Private Limited U51909MH2018PTC402763
Additional Director29 Jul 20242018₹54.76 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dial Health Drug Supplies Private Limited
Pearl Medicals Private Limited
D. C. Agencies Private Limited
Northmark Enterprises Llp
Premium access

Shareholding and investment profile for Manthan Bhavin Kothari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manthan Bhavin Kothari

Manthan Bhavin Kothari currently holds 4 directorships: D. C. Agencies Private Limited (Director, since 22 Aug 2024, revenue ₹284 Cr (FY 2024)); Pearl Medicals Private Limited (Director, since 22 Apr 2024, revenue ₹46.69 Cr (FY 2022)); Dial Health Drug Supplies Private Limited (Director, since 22 Aug 2024, revenue ₹27.3 Lakh (FY 2025)); Northmark Enterprises Llp (Designated Partner, since 19 Feb 2026).

Manthan Bhavin Kothari was first appointed on 22 Apr 2024 as Director at Pearl Medicals Private Limited. The most recent appointment on record is 19 Feb 2026 at Northmark Enterprises Llp.

The 3 current companies of Manthan Bhavin Kothari that report revenue have a combined latest revenue of ₹331 Cr: D. C. Agencies Private Limited ₹284 Cr (FY 2024); Pearl Medicals Private Limited ₹46.69 Cr (FY 2022); Dial Health Drug Supplies Private Limited ₹27.3 Lakh (FY 2025).

Manthan Bhavin Kothari held 1 earlier board appointment: Avighna Medicare Private Limited (Additional Director, 29 Jul 2024 to 22 Aug 2024).

The current boards of Manthan Bhavin Kothari's companies include Abhishek Kumar (D. C. Agencies Private Limited), Ashish Arora (D. C. Agencies Private Limited), Vineet Kumar (D. C. Agencies Private Limited), Darshan Anil Haria (Pearl Medicals Private Limited), Harshal Ashok Chaudhari (Pearl Medicals Private Limited), Srinivasa Ramanathan Manickam (Pearl Medicals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available